Fig. 1 · Structure
Documents & Downloads
Pecavaptan
V1a/V2 Receptor Antagonist
Pecavaptan is a selective antagonist of the V1a and V2 vasopressin receptors, exhibiting Ki values of 0.5 nM and 0.6 nM for human receptors, respectively. This compound enhances urine production, making it useful in research related to water retention and edema management. Its dual receptor activity positions Pecavaptan as a valuable tool in studies focused on renal physiology and vasopressin signaling pathways.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 1914998-56-3 |
| Applications | V1a/V2 Receptor Antagonist |
| Formula | C22H19Cl2F3N6O3 |
| Molecular Weight | 543.33 |
| Synonyms | BAY 1753011 |
| SMILES | O[C@H](C(F)(F)F)CN1C(C2=CC=C(Cl)C=C2)=NN(CC3=NN(C4=CC(Cl)=CC=C4)C([C@@H](O)C)=N3)C1=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.